Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops, manufactures and sells health care ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

Oppenheimer analyst Suraj Kalia maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

Abbott Laboratories (NYSE:ABT) rose 6% in after hours trading ... allege that the companies failed to warn parents about the ...

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.

Hundreds of lawsuits allege Abbott Laboratories’ formula for premature infants made babies sick. But is the formula to blame?